Publication Name	World Journal of Critical Care Medicine
Manuscript ID	100660
Country	Greece

Received	2024-08-22 09:44
Peer-Review Started	2024-08-22 09:44
To Make the First Decision
Return for Revision	2025-02-07 09:45
Revised	2025-02-25 12:01
Second Decision	2025-03-04 02:33
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-03-04 07:44
Articles in Press	2025-03-04 07:44
Publication Fee Transferred
Edit the Manuscript by Language Editor	2025-03-12 10:27
Typeset the Manuscript	2025-05-30 05:40
Publish the Manuscript Online	2025-07-18 15:29

ISSN	2220-3141(online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Minireviews
Article Title	Endocrine issues in critically ill transgender patients: A narrative review
Manuscript Source	Invited Manuscript
All Author List	Charalampos Milionis, Emmanouil Zoumakis, Athanasios Tselebis and Ioannis Ilias
Funding Agency and Grant Number
Corresponding Author	Ioannis Ilias, Director, MD, PhD, Department of Endocrinology, Hippocration General Hospital, 63 Evrou Street, Athens GR-11527, Greece. iiliasmd@yahoo.com
Key Words	Transgender; Critical illness; Gender-affirming hormone therapy; Endocrine alterations; Venous thromboembolism; Erythrocytosis; Hypothalamic-pituitary-adrenal axis; Intensive care unit
Core Tip	Critically ill transgender patients receiving gender-affirming hormone therapy present unique challenges in the intensive care unit, particularly regarding the increased risks of venous thromboembolism, erythrocytosis, and potential drug interactions. Understanding and managing these endocrine alterations are essential to optimizing care and improving outcomes in this vulnerable population.
Publish Date	2025-07-18 15:29
Citation	<p>Milionis C, Zoumakis E, Tselebis A, Ilias I. Endocrine issues in critically ill transgender patients: A narrative review. <i>World J Crit Care Med</i> 2025; 14(3): 100660</p>
URL	https://www.wjgnet.com/2220-3141/full/v14/i3/100660.htm
DOI	https://dx.doi.org/10.5492/wjccm.v14.i3.100660

Full Article (PDF)	WJCCM-14-100660-with-cover.pdf
Manuscript File	100660_Auto_Edited_015557.docx
Answering Reviewers	100660-answering-reviewers.pdf
Audio Core Tip	100660-audio.mp3
Conflict-of-Interest Disclosure Form	100660-conflict-of-interest-statement.pdf
Copyright License Agreement	100660-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	100660-non-native-speakers.pdf
Peer-review Report	100660-peer-reviews.pdf
Scientific Misconduct Check	100660-scientific-misconduct-check.png
Scientific Editor Work List	100660-scientific-editor-work-list.pdf
CrossCheck Report	100660-crosscheck-report.pdf